ArticleJournal of experimental & clinical cancer research : CR2017

Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death.

Marisa Granato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.